SEC Comment Letter for Xtant Medical Holdings, Inc. (XTNT) (CIK 0001453593) (XTNT) — Apr 2, 2024
Xtant Medical Holdings, Inc. (XTNT) (CIK 0001453593)
Date: April 2, 2024 · CIK: 0001453593 · Accession: 0000000000-24-003503
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278413
Letter
United States securities and exchange commission logo April 2, 2024 Sean Browne President and Chief Executive Officer Xtant Medical Holdings, Inc. 664 Cruiser Lane Belgrade, Montana 59714 Re:Xtant Medical Holdings, Inc. Registration Statement on Form S-3 Filed April 1, 2024 File No. 333-278413 Dear Sean Browne: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Amy Culbert
Show Raw Text
United States securities and exchange commission logo
April 2, 2024
Sean Browne
President and Chief Executive Officer
Xtant Medical Holdings, Inc.
664 Cruiser Lane
Belgrade, Montana 59714
Re:Xtant Medical Holdings, Inc.
Registration Statement on Form S-3
Filed April 1, 2024
File No. 333-278413
Dear Sean Browne:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Amy Culbert